Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

CRC Platform: A Colorectal Cancer Domain-specific Chemogenomics Knowledgebase for Polypharmacology and Target Identification Research

Yang, Xiaole (2015) CRC Platform: A Colorectal Cancer Domain-specific Chemogenomics Knowledgebase for Polypharmacology and Target Identification Research. Master's Thesis, University of Pittsburgh. (Unpublished)

[img]
Preview
PDF
Primary Text

Download (12MB)

Abstract

Colorectal cancer (CRC) is the third most common cancer, causing more than 600,000 deaths worldwide annually. Due to the involvement of complicated signaling pathways, epigenetic changes and genetic/genomic alterations, it is still challenging to develop effective treatments to reverse CRC progression. In order to facilitate developing new drugs for CRC treatment and revealing the mechanisms of CRC drug action at molecular level, we have constructed a computational CRC Platform (http://www.cbligand.org/CRC/), a domain-specific chemogenomics knowledgebase.

The CRC platform consists of four database modules, e.g. 762 CRC related genes and proteins, 411 known CRC drugs and chemicals, 168383 CRC related bioassays, and 269 CRC pathways, as well as searching tools for multi-function retrieval. It is also featured with powerful cloud computation technologies and computational tools to expedite target identification, polypharmacology and drug synergy analysis for CRC research.

We have also demonstrated the application of the CRC platform in the case studies: (1) computational exploration of FDA-approved CRC drugs for polypharmacology and drug synergy analysis; (2) in silico target identification of small chemical molecules from natural products with anti-CRC bioactivity; and (3) target identification and experimental validation for our in-house compounds. CRC platform will not only enrich our knowledge of CRC target identification, polypharmacology analysis, and biomarkers investigation, but also enhance the CRC chemogenomics data sharing and information exchange globally, and assist new drug design discovery and development for CRC treatment.


Share

Citation/Export:
Social Networking:
Share |

Details

Item Type: University of Pittsburgh ETD
Status: Unpublished
Creators/Authors:
CreatorsEmailPitt UsernameORCID
Yang, Xiaolexiy48@pitt.eduXIY48
ETD Committee:
TitleMemberEmail AddressPitt UsernameORCID
Committee ChairSant, Vinayakvis45@pitt.eduVIS45
Committee CoChairXie, Xiang-Qunxix15@pitt.eduXIX15
Committee MemberWang, Lirongliw30@pitt.eduLIW30
Date: 7 April 2015
Date Type: Publication
Defense Date: 27 March 2015
Approval Date: 7 April 2015
Submission Date: 6 April 2015
Access Restriction: 3 year -- Restrict access to University of Pittsburgh for a period of 3 years.
Number of Pages: 82
Institution: University of Pittsburgh
Schools and Programs: School of Pharmacy > Pharmaceutical Sciences
Degree: MS - Master of Science
Thesis Type: Master's Thesis
Refereed: Yes
Uncontrolled Keywords: colorectal cancer (CRC); chemogenomics database; cloud computation; target identification; polypharmacology; natural product; drug discovery
Date Deposited: 07 Apr 2015 19:15
Last Modified: 07 Apr 2018 05:15
URI: http://d-scholarship.pitt.edu/id/eprint/24550

Metrics

Monthly Views for the past 3 years

Plum Analytics


Actions (login required)

View Item View Item